Sucralfate: prophylaxis of mucosal damage during cancer therapy.

Sucralfate: prophylaxis of mucosal damage during cancer therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Sucralfate: prophylaxis of mucosal damage during cancer therapy. Abstract Text:

R Henriksson,L Franzén,C Edbom,B Littbrand,

BACKGROUND: Chemotherapy and radiotherapy of different malignancies may be complicated by a variety of side effects, some of which may be related mucosal damage. RESULTS: There is increasing evidence that sucralfate reduces the severity of radiation-induced mucositis in the head and neck, esophagus, and the lower gastrointestinal tract. Sucralfate also seems to protect the skin during radiotherapy and to reduce chemotherapy-induced mucositis. CONCLUSION: Further studies could be of interest to define the clinical significance of sucralfate in reducing the mucosal damage and increasing quality of life during an following cancer therapy.

Sucralfate: prophylaxis of mucosal damage during cancer therapy. Publishing Authors By Initials

R Henriksson,L Franzén,C Edbom,B Littbrand,

For similar organic chemicals: organometallic compounds: sucralfate research abstracts see: organic chemicals: organometallic compounds: sucralfate research

PUBMED ID PMID:

MEDLINE DATE:

Sucralfate: prophylaxis of mucosal damage during cancer therapy. Journal Published:

PUBLICATION TYPE: Review

Journal: Scandinavian journal of gastroenterology. Suppleme

VOLUME: 210

Page Numbers: 45-7

Journal Abbreviation: Scand. J. Gastroenterol. Suppl

ISSN: 0085-5928

DAY: 13

MONTH: 02

YEAR: 1995

Sucralfate: prophylaxis of mucosal damage during cancer therapy. Information

Number of References: 29

LANGUAGE: eng

NlmUniqueID: 437034

Sucralfate: prophylaxis of mucosal damage during cancer therapy. Keywords Mesh Terms:

KEYWORDS: Sucralfate

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Sucralfate: prophylaxis of mucosal damage during cancer therapy. Information

Substance Name: Sucralfate

Registry Number: 54182-58-0

Grant and Affiliation Information for Sucralfate: prophylaxis of mucosal damage during cancer therapy.

AFFILIATION: Dept. of Oncology, Umeá University Hospital, Sweden.

Country: NORWAY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Scand J Gastroenterol Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Sucralfate: prophylaxis of mucosal damage during cancer therapy Related Publications

• Managing side-effects in radiotherapy with regard to the gastrointestinal tract.
• Sucralfate: prophylaxis of mucosal damage during cancer therapy.